These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 811542)

  • 21. Autocatalytic activation of the proenzyme form of the C1s subunit of the first component of complement.
    Morgan PH; Nair IG
    Biochem Biophys Res Commun; 1975 Oct; 66(3):1037-41. PubMed ID: 1180942
    [No Abstract]   [Full Text] [Related]  

  • 22. The reactivity of the complement system.
    Hadding U
    Monogr Allergy; 1977; 12():36-45. PubMed ID: 335218
    [No Abstract]   [Full Text] [Related]  

  • 23. The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.
    Goers JW; Ziccardi RJ; Schumaker VN; Glovsky MM
    J Immunol; 1977 Jun; 118(6):2182-91. PubMed ID: 559020
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of an IgG fragment prepared with particulate plasmin to study the C1 binding and activation.
    Arlaud GJ; Meyer CM; Colomb MG
    FEBS Lett; 1976 Jul; 66(1):132-6. PubMed ID: 132372
    [No Abstract]   [Full Text] [Related]  

  • 25. C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.
    Suba EA; Csako G
    J Immunol; 1976 Jul; 117(1):304-9. PubMed ID: 1084367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement.
    Isenman DE; Dorrington KJ; Painter RH
    J Immunol; 1975 Jun; 114(6):1726-9. PubMed ID: 1127227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biochemistry of complement.
    Porter RR; Reid KB
    Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amino acid sequence similarities between amyloid P component C1t and CRP.
    Levo Y; Frangione B; Franklin EC
    Nature; 1977 Jul; 268(5615):56-7. PubMed ID: 887146
    [No Abstract]   [Full Text] [Related]  

  • 30. Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.
    Bartholomew RM; Esser AF; Müller-Eberhard HJ
    J Exp Med; 1978 Mar; 147(3):844-53. PubMed ID: 632750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of a high-affinity binding site for the globular head regions of the C1q complement protein on a human diploid fibroblast subtype.
    Bordin S; Page RC
    Mol Immunol; 1989 Jul; 26(7):677-85. PubMed ID: 2789337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: C1-esterase inactivators and C4 in malignant diseases.
    Bach-Martensen N; Osther K; Stroyer I
    Lancet; 1975 Sep; 2(7933):499-500. PubMed ID: 51308
    [No Abstract]   [Full Text] [Related]  

  • 33. C1-bypass complement-activation pathway in patients with chronic urticaria and angio-oedema.
    Ballow M; Ward GW; Gershwin ME; Day NK
    Lancet; 1975 Aug; 2(7928):248-50. PubMed ID: 49798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inactivator of the first component of human complement (C1INA): the complex formation with plasmin.
    Nagaki K; Hashimoto C; Inai S
    Int Arch Allergy Appl Immunol; 1976; 50(1):1-13. PubMed ID: 126969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM; Bhat KN; Crown R
    J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The macromolecular structure of the first component of complement.
    Assimeh SN; Painter RH
    J Immunol; 1975 Aug; 115(2):488-94. PubMed ID: 807640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the exposure of aromatic chromophores at the surface of the Fc domains of immunoglobulin G and their ability to bind complement.
    Isenman DE; Ellerson JR; Painter RH; Dorrington KJ
    Biochemistry; 1977 Jan; 16(2):233-40. PubMed ID: 13808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of dithiothreitol on agglutination and complement fixation by porcine 19 S IgM.
    Beale D; Kent CM
    Biochim Biophys Acta; 1977 Sep; 494(1):209-21. PubMed ID: 901806
    [No Abstract]   [Full Text] [Related]  

  • 39. Derivatives of the complement component MuB1 (C5mu) and separation of a factor involved in the conversion of MuB1 to MuB1f.
    Naylor DH; Cinader B
    Int Arch Allergy Appl Immunol; 1970; 39(5-6):540-65. PubMed ID: 4250087
    [No Abstract]   [Full Text] [Related]  

  • 40. Functionally active C1 on the surface of human peripheral lymphocytes: its role in the complement-mediated inhibition of the Fc receptor of B lymphocytes.
    Füst G; Erdei A; Sármay G; Medgyesi GA; Gergely J
    Clin Immunol Immunopathol; 1976 May; 5(3):377-87. PubMed ID: 776475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.